Form 4 for VOR Vor Biopharma Inc.
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0001415889-24-003041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | 2024-02-06 | VOR | Attar Eyal C. | Chief MEDICAL Off | F - Tax | $2.32 | -1,180 | 112.9K | -1% | -$2,738 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-06 | F | D | 1,180 | $2.32 | 112,853 | D | — | — | (F1) Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |